Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Eythstr. 24, 89075, Ulm, Germany.Maximilian Felix.SteinhauserDepartment of Pediatrics and Children's Cancer Research Center (CCRC), Technische Universität München, Koelner Platz 1, 80804, Munich, Germany.Klaus-Michael....
Precision medicine in pediatric oncology: Lessons learned and next steps The maturation of genomic technologies has enabled new discoveries in disease pathogenesis as well as new approaches to patient care. In pediatric oncology... RJ Mody,JR Prensner,J Everett,... - 《Pediatric Blood & Cancer》...
Ongoing Research Advances Equity and Precision Oncology Through Tissue-Agnostic Therapies: With Chandler Park, MD, and Vivek Subbiah, MD Kalyan and Mouli Provide Perspective on the Power of Personalized Medicine in HCC Gordan on Growing the Infrastructure for In-House Genomic Testing FDA Approval In...
Precision medicine in pediatric oncology. Curr Opin Pediatr. 2018;30(1):17–24. https://doi.org/10.1097/MOP.0000000000000570. Article PubMed Google Scholar Hartmaier RJ, Albacker LA, Chmielecki J, Bailey M, He J, Goldberg ME, et al. High-throughput genomic profiling of adult solid ...
The development of next-generation sequencing (NGS) in conjunction with targeted anticancer therapies has allowed the delivery of precision medicine, selecting for the molecular drivers of a patient’s cancer. Pediatric precision oncology studies have identified potentially targetable molecular findings in ...
Precision medicine in pediatric cancer: current applications and future prospects. High Throughput 7,39 (2018). Gounder, M. M. et al. Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma. Nat. Commun. 13, 3406 (2022). Article CAS PubMed PubMed Central...
Precision medicine in cancer treatment, or precision oncology, is also called “personalized medicine” and is a rapidly evolving approach to cancer treatment and prevention that allows physicians to select treatments that are most likely to help patients based on a genetic understanding of their ...
comprehensive genomic profiling is playing a growing role in the clinical management of BTCs. Currently however, there is only one precision medicine approved by the US Food and Drug Administration (FDA) for the treatment of BTCs. Herein, we highlight the prevalence and prognostic, diagnostic, and...
The OncLive Precision Medicine in Oncology® condition center page is a comprehensive resource for clinical news and expert insights on precision-focused approaches in patients with cancer, with gene-targeted tyrosine kinase inhibitors and antibody-drug conjugates, checkpoint inhibitors, tumor-infiltrating...
Accenture puts data science to work for pediatric leukemia research This approach aims to enable pediatric oncology physicians and researchers to better analyze patient data, with the potential to improve precision medicine. READ MORE Voices of Life Sciences Life Sciences consultants weigh in on how ...